Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III).
Engel C, Rüdiger M, Benders MJNL, van Bel F, Allegaert K, Naulaers G, Bassler D, Klebermaß-Schrehof K, Vento M, Vilan A, Falck M, Mauro I, Metsäranta M, Vanhatalo S, Mazela J, Metsvaht T, van der Vlught R, Franz AR; ALBINO Study Group. Engel C, et al. Among authors: mauro i. Trials. 2024 Mar 15;25(1):192. doi: 10.1186/s13063-024-08031-x. Trials. 2024. PMID: 38491488 Free PMC article. No abstract available.
Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III).
Engel C, Rüdiger M, Benders MJNL, van Bel F, Allegaert K, Naulaers G, Bassler D, Klebermaß-Schrehof K, Vento M, Vilan A, Falck M, Mauro I, Metsäranta M, Vanhatalo S, Mazela J, Metsvaht T, van der Vlught R, Franz AR; ALBINO Study Group. Engel C, et al. Among authors: mauro i. Trials. 2024 Jan 24;25(1):81. doi: 10.1186/s13063-023-07828-6. Trials. 2024. PMID: 38267942 Free PMC article. Clinical Trial.
Supporting Return to Work after Breast Cancer: A Mixed Method Study.
Magnavita N, Di Prinzio RR, Meraglia I, Vacca ME, Arnesano G, Merella M, Mauro I, Iuliano A, Terribile DA. Magnavita N, et al. Among authors: mauro i. Healthcare (Basel). 2023 Aug 19;11(16):2343. doi: 10.3390/healthcare11162343. Healthcare (Basel). 2023. PMID: 37628540 Free PMC article.
BRCA1/2 Pathogenic Variants Are Not Common in Merkel Cell Carcinoma: Comprehensive Molecular Study of 30 Cases and Meta-Analysis of the Literature.
Gaubert A, Kervarrec T, Montaudié H, Burel-Vandenbos F, Cardot-Leccia N, Di Mauro I, Fabas T, Tallet A, Kubiniek V, Pedeutour F, Dadone-Montaudié B. Gaubert A, et al. Among authors: di mauro i. J Invest Dermatol. 2023 Jul;143(7):1178-1186. doi: 10.1016/j.jid.2023.01.014. Epub 2023 Feb 7. J Invest Dermatol. 2023. PMID: 36754117 Free article.
Clinicopathologic and molecular analyses of cutaneous leiomyosarcoma: A retrospective, multicenter study of 79 cases.
Planet C, Dalle S, Dereure O, Stoebner PE, Picot MC, Soler M, Meunier L, Cardot-Leccia N, Kubiniek V, Di Mauro I, Delhorbe M, Lacour JP, Passeron T, Pedeutour F, Montaudié H, Dadone-Montaudié B. Planet C, et al. Among authors: di mauro i. J Am Acad Dermatol. 2023 Jan;88(1):215-216. doi: 10.1016/j.jaad.2022.03.066. Epub 2022 Apr 27. J Am Acad Dermatol. 2023. PMID: 35489551 No abstract available.
40 results